---
figid: PMC7555335__biomedicines-08-00316-g003
figtitle: Constitutive activation of STAT5
organisms:
- Homo sapiens
- Mus musculus
pmcid: PMC7555335
filename: biomedicines-08-00316-g003.jpg
figlink: pmc/articles/PMC7555335/figure/biomedicines-08-00316-f003/
number: F3
caption: 'Mechanism of constitutive activation of STAT5. STAT5 is activated by: (a)
  increased signalling by cytokines and their receptors (interleukin-15 (IL-15), IL-6,
  erythropoietin receptor (EpoR), and IL-6 receptor (IL-6R)), receptor tyrosine kinases
  (RTKs), e.g., epidermal growth factor receptor (EGFR), and Flt3, as well as non-receptor
  tyrosine kinases (nRTKs), such as Src family kinases (SFKs), JAK2 and Bcr-Abl; (b)
  downregulation of negative regulators of STAT5 pathway, e.g., SOCS inhibited through
  IL-23 signalling and PIAS; (c) cross-talk with other signalling pathways, e.g.,
  mammalian target of rapamycin (mTOR) and androgen receptor (AR) pathways; and (d)
  activating STAT5 mutations and increased STAT5 expression.'
papertitle: Involvement of STAT5 in Oncogenesis.
reftext: Clarissa Esmeralda Halim, et al. Biomedicines. 2020 Sep;8(9):316.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9495994
figid_alias: PMC7555335__F3
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC7555335__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7555335__biomedicines-08-00316-g003.html
  '@type': Dataset
  description: 'Mechanism of constitutive activation of STAT5. STAT5 is activated
    by: (a) increased signalling by cytokines and their receptors (interleukin-15
    (IL-15), IL-6, erythropoietin receptor (EpoR), and IL-6 receptor (IL-6R)), receptor
    tyrosine kinases (RTKs), e.g., epidermal growth factor receptor (EGFR), and Flt3,
    as well as non-receptor tyrosine kinases (nRTKs), such as Src family kinases (SFKs),
    JAK2 and Bcr-Abl; (b) downregulation of negative regulators of STAT5 pathway,
    e.g., SOCS inhibited through IL-23 signalling and PIAS; (c) cross-talk with other
    signalling pathways, e.g., mammalian target of rapamycin (mTOR) and androgen receptor
    (AR) pathways; and (d) activating STAT5 mutations and increased STAT5 expression.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Il15
  - Il6
  - Egf
  - Tgfa
  - Il6ra
  - Epor
  - Egfr
  - Flt3
  - Il23a
  - Jak2
  - Cish
  - Bcl2
  - Bc1
  - Bc1-ps1
  - Igkv1-136
  - Bcl2l1
  - Mcl1
  - Mmp9
  - Pim1
  - Cs
  - Mtor
  - IL15
  - IL6
  - EGF
  - TGFA
  - IL6R
  - EPOR
  - EGFR
  - FLT3
  - IL37
  - IL23A
  - JAK2
  - ABL1
  - CISH
  - BCL2
  - CHMP2A
  - BCL2L1
  - CCND1
  - CCND2
  - CCND3
  - MCL1
  - MMP9
  - PIM1
  - LONP1
  - MTOR
---
